Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index

Obesity

Volumn 25, Issue 4, 2017, Pages 794-800

  Chen, Guanjie ^a   Doumatey, Ayo P ^a   Zhou, Jie ^a   Lei, Lin ^a   Bentley, Amy R ^a   Tekola Ayele, Fasil ^a   Adebamowo, Sally N ^a   Baker, Jennifer L ^a   Fasanmade, Olufemi ^b   Okafor, Godfrey ^c   Eghan, Benjamin ^d   Agyenim Boateng, Kofi ^d   Amoah, Albert ^e   Adebamowo, Clement ^f   Acheampong, Joseph ^d   Johnson, Thomas ^b   Oli, Johnnie ^c   Shriner, Daniel ^a   Adeyemo, Adebowale A ^a   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LAGOS   (Nigeria)

^c UNIVERSITY OF NIGERIA   (Nigeria)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^e UNIVERSITY OF GHANA   (Ghana)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; CD100 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AFRICAN; AFRICAN AMERICAN; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGED; MINOR ALLELE FREQUENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POPULATION GENETICS; PREVALENCE; PROTEIN BLOOD LEVEL; SEMA4D GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; VALIDATION PROCESS; WEST AFRICAN; AFRICA; ALLELE; BLACK PERSON; BLOOD; GENETICS;

AFRICA, WESTERN; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANTIGENS, CD; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEMAPHORINS;

EID: 85015206567     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21804     Document Type: Article

References (31)

1. Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care 2015;38:1567-1582.
2. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997;27:325-351.
3. Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014;42(Database issue):D1001-1006.
4. Chen G, Adeyemo AA, Johnson T, et al. A genome-wide scan for quantitative trait loci linked to obesity phenotypes among West Africans. Int J Obes (Lond) 2005;29:255-259.
5. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M. Genome-wide association studies in diverse populations. Nat Rev Genet 2010;11:356-366.
6. Rotimi CN, Dunston GM, Berg K, et al. In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol 2001;11:51-58.
7. Screening for type 2 diabetes. Diabetes Care 2000;23(Suppl 1):S20-S23.
8. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23(10):1563-1580.
9. Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013;10:5-6.
10. Liu EY, Li M, Wang W, Li Y. MaCH-admix: genotype imputation for admixed populations. Genet Epidemiol 2013;37:25-37.
11. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-834.
12. Monda KL, Chen GK, Taylor KC, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013;45:690-696.
13. Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 2012;28:3326-3328.
14. Li Y, Willer C, Sanna S, Abecasis G. Genotype imputation. Annu Rev Genomics Hum Genet 2009;10:387-406.
15. Pedroso I, Breen G. Gene set analysis and network analysis for genome-wide association studies. Cold Spring Harb Protoc 2011;2011(9). doi:10.1101/pdb.top065581.
16. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008;32:227-234.
17. Yu B, Zheng Y, Alexander D, et al. Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. Gen Epidemiol 2013;37:840-845.
18. Dean DA, 2nd, Goldberger AL, Mueller R, et al. Scaling up scientific discovery in sleep medicine: the National Sleep Research Resource. Sleep 2016;39:1151-1164.
19. Adeyemo A, Gerry N, Chen G, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009;5:e1000564. doi:10.1371/journal.pgen.1000564.
20. Fox ER, Sarpong DF, Cook JC, et al. The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: the Jackson Heart Study. Diabetes Care 2011;34:507-509.
21. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-881.
22. The ARIC Investigators. Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989;129:687-702.
23. Redline S, Tishler PV, Tosteson TD, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995;151(3 Pt 1):682-687.
24. Taylor HA Jr, Wilson JG, Jones DW, et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis 2005;15(4 Suppl 6):S6-4-S6-17.
25. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40(Database issue):D930-D934.
26. Worzfeld T, Offermanns S. Semaphorins and plexins as therapeutic targets. Nat Rev Drug Discov 2014;13:603-621.
27. Lu QY, Dong NZ, Wang Q, et al. Increased levels of plasma soluble Sema4D in patients with heart failure. PLoS One 2013;8:e64265. doi:10.1371/journal.pone.0064265.
28. Bertola A, Bonnafous S, Anty R, et al. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One 2010;5:e13577. doi:10.1371/journal.pone.0013577.
29. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007;115:1029-1038.
30. Mizui M, Kumanogoh A, Kikutani H. Immune semaphorins: novel features of neural guidance molecules. J Clin Immunol 2009;29:1-11, doi:10.1007/s10875-008-9263-7.
31. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010;18:1918-1925.